230 related articles for article (PubMed ID: 27348967)
1. Enhanced skin penetration of lidocaine through encapsulation into nanoethosomes and nanostructured lipid carriers: a comparative study.
Babaei S; Ghanbarzadeh S; Adib ZM; Kouhsoltani M; Davaran S; Hamishehkar H
Pharmazie; 2016 May; 71(5):247-51. PubMed ID: 27348967
[TBL] [Abstract][Full Text] [Related]
2. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
3. Development, characterization, and in vitro and in vivo evaluation of benzocaine- and lidocaine-loaded nanostructrured lipid carriers.
Puglia C; Sarpietro MG; Bonina F; Castelli F; Zammataro M; Chiechio S
J Pharm Sci; 2011 May; 100(5):1892-9. PubMed ID: 21374621
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of lidocaine hydrochloride-loaded TAT-conjugated polymeric liposomes for transdermal delivery.
Wang Y; Su W; Li Q; Li C; Wang H; Li Y; Cao Y; Chang J; Zhang L
Int J Pharm; 2013 Jan; 441(1-2):748-56. PubMed ID: 23089577
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery.
Pathak P; Nagarsenker M
AAPS PharmSciTech; 2009; 10(3):985-92. PubMed ID: 19641997
[TBL] [Abstract][Full Text] [Related]
6. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery.
Chen-yu G; Chun-fen Y; Qi-lu L; Qi T; Yan-wei X; Wei-na L; Guang-xi Z
Int J Pharm; 2012 Jul; 430(1-2):292-8. PubMed ID: 22486962
[TBL] [Abstract][Full Text] [Related]
7. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.
Elnaggar YS; El-Massik MA; Abdallah OY
Int J Nanomedicine; 2011; 6():3195-205. PubMed ID: 22238508
[TBL] [Abstract][Full Text] [Related]
8. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
[TBL] [Abstract][Full Text] [Related]
9. Development of thermodynamically stable nanostructured lipid carrier system using central composite design for zero order permeation of econazole nitrate through epidermis.
Keshri L; Pathak K
Pharm Dev Technol; 2013; 18(3):634-44. PubMed ID: 22339250
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil.
Rajinikanth PS; Chellian J
Int J Nanomedicine; 2016; 11():5067-5077. PubMed ID: 27785014
[TBL] [Abstract][Full Text] [Related]
11. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis.
Gupta M; Vyas SP
Chem Phys Lipids; 2012 May; 165(4):454-61. PubMed ID: 22309657
[TBL] [Abstract][Full Text] [Related]
12. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
Kawadkar J; Pathak A; Kishore R; Chauhan MK
Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.
Hsu SH; Wen CJ; Al-Suwayeh SA; Chang HW; Yen TC; Fang JY
Nanotechnology; 2010 Oct; 21(40):405101. PubMed ID: 20823498
[TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
Liu R; Liu Z; Zhang C; Zhang B
J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
[TBL] [Abstract][Full Text] [Related]
15. Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.
Chen Y; Zhou L; Yuan L; Zhang ZH; Liu X; Wu Q
Int J Nanomedicine; 2012; 7():3023-32. PubMed ID: 22787398
[TBL] [Abstract][Full Text] [Related]
16. Preparation and Characterization of Nanostructured Lipid Carriers for Improved Topical Drug Delivery: Evaluation in Cutaneous Leishmaniasis and Vaginal Candidiasis Animal Models.
Riaz A; Hendricks S; Elbrink K; Guy C; Maes L; Ahmed N; Kiekens F; Khan GM
AAPS PharmSciTech; 2020 Jul; 21(5):185. PubMed ID: 32632542
[TBL] [Abstract][Full Text] [Related]
17. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis.
Agrawal Y; Petkar KC; Sawant KK
Int J Pharm; 2010 Nov; 401(1-2):93-102. PubMed ID: 20858539
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate.
Abdelbary G; Haider M
Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084
[TBL] [Abstract][Full Text] [Related]
20. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
Liu J; Hu W; Chen H; Ni Q; Xu H; Yang X
Int J Pharm; 2007 Jan; 328(2):191-5. PubMed ID: 16978810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
